Stenosing Tenosynovitis
9
3
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
11%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (9)
Prospective Randomized Trial Comparing Longitudinal vs. Transverse A1 Pulley Release
Effectiveness of Conservative Interventions in the Treatment of Trigger Finger
Resection of Flexor Digitorum Superficialis Tendon for Severe Trigger Fingers
Comparing Relative Motion Splint and Metacarpophalangeal Joint Blocking Splint for Trigger Finger
Focused Extracorporeal Shock Wave Therapy (ESWT) Versus Traditional Physiotherapy in the Treatment of Trigger Finger
Trigger Finger Treatment
Corticosteroid vs. Amniotic Fluid Injections in Patients With Trigger Finger
Treatment of Trigger Finger With Steroid Injection Versus Steroid Injection and Splinting
Study Comparing One Versus Two Cortisone Injections for Trigger Finger